Therapeutic efficacy and safety of red blood cells treated with a chemical process (S-303) for pathogen inactivation: A Phase III clinical trial in cardiac surgery patients
- Richard J. Benjamin
- , Jeffrey McCullough
- , Paul D. Mintz
- , Edward Snyder
- , William D. Spotnitz
- , Robert J. Rizzo
- , David Wages
- , Jin Sying Lin
- , Lindsey Wood
- , Laurence Corash
- , Maureen G. Conlan
Research output: Contribution to journal › Article › peer-review
73
Link opens in a new tab
Scopus
citations